Targeted radionuclide therapy for patients with metastatic pheochromocytoma and paraganglioma: From low-specific-activity to high-specific-activity iodine-131 metaiodobenzylguanidine

Camilo Jimenez, William Erwin, Beth Chasen

Research output: Contribution to journal › Review article › peer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'Targeted radionuclide therapy for patients with metastatic pheochromocytoma and paraganglioma: From low-specific-activity to high-specific-activity iodine-131 metaiodobenzylguanidine'. Together they form a unique fingerprint.

Medicine & Life Sciences